TENS device study for endometriosis pain withdrawn before start
NCT ID NCT06914752
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study planned to see if a TENS device could reduce pain and improve quality of life in adolescents and young adults with endometriosis-related chronic pelvic pain. It was withdrawn before any participants were enrolled, so no data was collected. The goal was to offer a non-drug pain relief option for this age group.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- transcutaneous electrical nerve stimulation (TENS) device
- What this could lead to
- If it had been tested, TENS could offer a drug-free way to ease pelvic pain and improve daily life for young people with endometriosis.
- What could go wrong
- The study was withdrawn before enrolling anyone, so no results are available. TENS may not work for everyone, and its effects can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Expected to start
-
Sep 2025
An estimate. Start dates often move.
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
10 to 21 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adolescent girls and young women (13-25) * Diagnosis of endometriosis, * Current pelvic pain (score ≥ 3 on Visual Analog Scale, where 0 represents absence of pain and 10 indicates unbearable pain) present for ≥ 14 days/month over the 2 months prior to study enrollment. * Personal smart phone or mobile device * Speak either English or Spanish.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Endometriosis (diagnosis) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Allergy pill put to the test against endometriosis pain
- Can common endometriosis drugs change blood flow in the brain?
- Can fish oils calm endometriosis inflammation?
- Can surgery save the kidneys in deep endometriosis?
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Saliva test for endometriosis: will it improve Women's lives?